Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexander C. Belshoff"'
Autor:
Teresa W.-M. Fan, Jason Winnike, Ahmad Al-Attar, Alexander C. Belshoff, Pawel K. Lorkiewicz, Jin Lian Tan, Min Wu, Richard M. Higashi, Andrew N. Lane
Publikováno v:
Metabolites, Vol 13, Iss 7, p 774 (2023)
Past chemopreventive human trials on dietary selenium supplements produced controversial outcomes. They largely employed selenomethionine (SeM)-based diets. SeM was less toxic than selenite or methylseleninic acid (MSeA) to lung cancer cells. We thus
Externí odkaz:
https://doaj.org/article/d138aeef22d54272a4f32cf81e8a1281
Autor:
Lane, Teresa W.-M. Fan, Jason Winnike, Ahmad Al-Attar, Alexander C. Belshoff, Pawel K. Lorkiewicz, Jin Lian Tan, Min Wu, Richard M. Higashi, Andrew N.
Publikováno v:
Metabolites; Volume 13; Issue 7; Pages: 774
Past chemopreventive human trials on dietary selenium supplements produced controversial outcomes. They largely employed selenomethionine (SeM)-based diets. SeM was less toxic than selenite or methylseleninic acid (MSeA) to lung cancer cells. We thus
Autor:
Richard M. Higashi, Andrew N. Lane, Michael Bousamra, Teresa W.-M. Fan, Alexander C. Belshoff, Jeremiah T. Martin
Publikováno v:
Cancer Research. 75:3199-3199
Introduction: All preclinical drug testing models have advantages and drawbacks. We have been using SIRM to evaluate metabolic reprogramming of lung cancer cells in monoculture, in mouse xenograft/explant models, and in NSCLC patients in situ (1), an